Barnes S, Whistler H L, Hughes J, Woodruff G N, Hunter J C
Parke Davis Research Unit, Addenbrookes Hospital Site, Cambridge, England.
J Neurochem. 1991 Apr;56(4):1409-16. doi: 10.1111/j.1471-4159.1991.tb11439.x.
The sulphated octapeptide of cholecystokinin (CCK-8S) was found to cause a dose-dependent increase in the basal release of aspartate, glycine, and gamma-aminobutyric acid from the striatum and the ventromedial nucleus of the hypothalamus (VMH). No effect on amino acid release was observed after electrical (VMH) or potassium (striatum) stimulation. Experiments performed using the CCKB-selective antagonist L-365,260 and the CCKA-selective antagonist L-364,718 suggested that this action of CCK-8S was mediated via the CCKB receptor. The ability of CCK-8S to evoke amino acid release was not dependent on the presence of extracellular calcium, though the effect was abolished by tetrodotoxin. Inhibition of protein kinase activity by staurosporine prevented the excitatory effects of CCK-8S on amino acid release.
发现胆囊收缩素的硫酸化八肽(CCK - 8S)可使纹状体和下丘脑腹内侧核(VMH)中天门冬氨酸、甘氨酸和γ-氨基丁酸的基础释放呈剂量依赖性增加。电刺激(VMH)或钾刺激(纹状体)后未观察到对氨基酸释放有影响。使用CCKB选择性拮抗剂L - 365,260和CCKA选择性拮抗剂L - 364,718进行的实验表明,CCK - 8S的这一作用是通过CCKB受体介导的。CCK - 8S诱发氨基酸释放的能力不依赖于细胞外钙的存在,不过该效应被河豚毒素消除。星形孢菌素抑制蛋白激酶活性可阻止CCK - 8S对氨基酸释放的兴奋作用。